- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
DIY healthcare tops PwC’s HRI 10 issues for 2015
PwC’s Health Research Institute (HRI) announced its top 10 health industry issues for 2015.
PwC’s Health Research Institute (HRI) announced its top 10 health industry issues for 2015.
The HRI’s top three emphasizes the possibilities of mobile device technologies for do-it-yourself (DIY) healthcare and the potential privacy concerns that could arise.
The list also highlights high-cost patients and the need for innovations that reduce cost and improve outcomes (#’s four and five).
Rounding out the top 10: transparency initiatives targeting clinical trial data, the emerging portrait of the newly-insured, physician “extenders” in the first line of care, redefining health and well-being for the millennial generation and partnerships pushing healthcare companies toward new competitive strategies.
PwC compiles the top list via a survey of 1,000 U.S. consumers and interviews with health industry leaders, according to its press release.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
